FdaApplication
NDA 016295
Identifiers
- fda_app_no: NDA016295
Properties
| Property | Value |
|---|---|
| applicant_name | WAYLIS THERAPEUTICS LLC |
| application_type | NDA |
| approval_date | 1998-02-25 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DROXIA | HYDROXYUREA | 200MG | CAPSULE;ORAL |
| DROXIA | HYDROXYUREA | 400MG | CAPSULE;ORAL |
| DROXIA | HYDROXYUREA | 300MG | CAPSULE;ORAL |
| HYDREA | HYDROXYUREA | 500MG | CAPSULE;ORAL |
4 products